Shares of Valeant (VRX -2.3%) hit some volatility this morning after its 2012 guidance...


Shares of Valeant (VRX -2.3%) hit some volatility this morning after its 2012 guidance presentation. The company sees Q4 earnings in the mid-range of estimates, while it ups 2012 EPS estimates to between $3.95 - $4.20. More importantly, the company says there's still no agreement on the buyout process or price with Ista Pharmaceuticals (ISTA -0.4%), following Ista's rejection of its recent bid in December, and puts a drop dead date of January 31 for negotiations.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs